Skip to main content
. 2022 Jan 13;9(2):e1120. doi: 10.1212/NXI.0000000000001120

Table 2.

Distribution of Comorbidities, Baseline MRI Measures, Baseline DMT, and DMT Changes During Follow-up Stratified by the Presence of New Lesions and Their CVS Characteristics

graphic file with name NEURIMMINFL2021039347t2.jpg